{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "0b0a1607",
   "metadata": {},
   "source": [
    "### EuCT Data Cleaning:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ba3e23d8",
   "metadata": {},
   "source": [
    "#### Library and Data Import:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "33580fad",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "5b147f5b",
   "metadata": {},
   "outputs": [],
   "source": [
    "path = os.getcwd()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "69faf657",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_csv(r'C:\\Users\\ggrkn\\OneDrive - NOVAIMS\\PostGrad\\PDS\\_Final Project\\EuCTRegister.csv', low_memory=False)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d6bb49cb",
   "metadata": {},
   "source": [
    "#### Column Selection and Aggregation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "de62c388",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(114333, 181)"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.shape"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b6eb854e",
   "metadata": {},
   "source": [
    "The original dataset has 114333 rows and 181 columns so we need to clean it before any analysis.\n",
    "\n",
    "By their names, we selected a set of 26 possible columns that might interest us"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "cc18c7b0",
   "metadata": {},
   "outputs": [],
   "source": [
    "column_list=['EudraCT Number:','Country','Member State Concerned',\n",
    "             'Date on which this record was first entered in the EudraCT database:','Date of the global end of the trial',\n",
    "             'Trial Status:','Therapeutic area','Diagnosis','Prophylaxis','Therapy','Safety','Efficacy',\n",
    "             'Main objective of the trial','Human pharmacology (Phase I)','Therapeutic exploratory (Phase II)',\n",
    "             'Therapeutic confirmatory (Phase III)','Therapeutic use (Phase IV)','In Utero','Newborns (0-27 days)',\n",
    "             'Infants and toddlers (28 days-23 months)','Children (2-11years)','Adolescents (12-17 years)',\n",
    "             'Adults (18-64 years)','Elderly (>=65 years)','Female','Male', 'Medical condition(s) being investigated', 'Medical condition in easily understood language']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "50913261",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "28"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(column_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "2f8f4a23",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.loc[:,column_list]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bb0aa492",
   "metadata": {},
   "source": [
    "As we can see by the table below there are a lot of columns that are 'dummy' columns that can probably be aggregated to simplify the analysis."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "f5ed2a14",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>count</th>\n",
       "      <th>unique</th>\n",
       "      <th>top</th>\n",
       "      <th>freq</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>EudraCT Number:</th>\n",
       "      <td>114290</td>\n",
       "      <td>43464</td>\n",
       "      <td>2017-004295-55</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Country</th>\n",
       "      <td>77738</td>\n",
       "      <td>88</td>\n",
       "      <td>United States</td>\n",
       "      <td>17694</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Member State Concerned</th>\n",
       "      <td>112737</td>\n",
       "      <td>31</td>\n",
       "      <td>Spain - AEMPS</td>\n",
       "      <td>11095</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Date on which this record was first entered in the EudraCT database:</th>\n",
       "      <td>114290</td>\n",
       "      <td>4993</td>\n",
       "      <td>2021-06-17</td>\n",
       "      <td>327</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Date of the global end of the trial</th>\n",
       "      <td>63363</td>\n",
       "      <td>5511</td>\n",
       "      <td>2012-12-20</td>\n",
       "      <td>60</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Trial Status:</th>\n",
       "      <td>111285</td>\n",
       "      <td>10</td>\n",
       "      <td>Completed</td>\n",
       "      <td>66850</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Therapeutic area</th>\n",
       "      <td>78199</td>\n",
       "      <td>55</td>\n",
       "      <td>Diseases [C] - Cancer [C04]</td>\n",
       "      <td>21952</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Diagnosis</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>No</td>\n",
       "      <td>108189</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Prophylaxis</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>No</td>\n",
       "      <td>103340</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Therapy</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>Yes</td>\n",
       "      <td>63972</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Safety</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>Yes</td>\n",
       "      <td>103257</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Efficacy</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>Yes</td>\n",
       "      <td>101944</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Main objective of the trial</th>\n",
       "      <td>113518</td>\n",
       "      <td>63401</td>\n",
       "      <td>Demonstrate that ofatumumab 20 mg sc once ever...</td>\n",
       "      <td>27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Human pharmacology (Phase I)</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>No</td>\n",
       "      <td>106469</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Therapeutic exploratory (Phase II)</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>No</td>\n",
       "      <td>70268</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Therapeutic confirmatory (Phase III)</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>Yes</td>\n",
       "      <td>60094</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Therapeutic use (Phase IV)</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>No</td>\n",
       "      <td>98019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>In Utero</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>No</td>\n",
       "      <td>93835</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Newborns (0-27 days)</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>No</td>\n",
       "      <td>92170</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Infants and toddlers (28 days-23 months)</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>No</td>\n",
       "      <td>88099</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Children (2-11years)</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>No</td>\n",
       "      <td>82205</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Adolescents (12-17 years)</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>No</td>\n",
       "      <td>78255</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Adults (18-64 years)</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>Yes</td>\n",
       "      <td>102709</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Elderly (&gt;=65 years)</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>Yes</td>\n",
       "      <td>86288</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Female</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>Yes</td>\n",
       "      <td>109773</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Male</th>\n",
       "      <td>114290</td>\n",
       "      <td>3</td>\n",
       "      <td>Yes</td>\n",
       "      <td>107306</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Medical condition(s) being investigated</th>\n",
       "      <td>113879</td>\n",
       "      <td>47691</td>\n",
       "      <td>Rheumatoid Arthritis</td>\n",
       "      <td>694</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Medical condition in easily understood language</th>\n",
       "      <td>77422</td>\n",
       "      <td>31165</td>\n",
       "      <td>Asthma</td>\n",
       "      <td>607</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                     count unique  \\\n",
       "EudraCT Number:                                     114290  43464   \n",
       "Country                                              77738     88   \n",
       "Member State Concerned                              112737     31   \n",
       "Date on which this record was first entered in ...  114290   4993   \n",
       "Date of the global end of the trial                  63363   5511   \n",
       "Trial Status:                                       111285     10   \n",
       "Therapeutic area                                     78199     55   \n",
       "Diagnosis                                           114290      3   \n",
       "Prophylaxis                                         114290      3   \n",
       "Therapy                                             114290      3   \n",
       "Safety                                              114290      3   \n",
       "Efficacy                                            114290      3   \n",
       "Main objective of the trial                         113518  63401   \n",
       "Human pharmacology (Phase I)                        114290      3   \n",
       "Therapeutic exploratory (Phase II)                  114290      3   \n",
       "Therapeutic confirmatory (Phase III)                114290      3   \n",
       "Therapeutic use (Phase IV)                          114290      3   \n",
       "In Utero                                            114290      3   \n",
       "Newborns (0-27 days)                                114290      3   \n",
       "Infants and toddlers (28 days-23 months)            114290      3   \n",
       "Children (2-11years)                                114290      3   \n",
       "Adolescents (12-17 years)                           114290      3   \n",
       "Adults (18-64 years)                                114290      3   \n",
       "Elderly (>=65 years)                                114290      3   \n",
       "Female                                              114290      3   \n",
       "Male                                                114290      3   \n",
       "Medical condition(s) being investigated             113879  47691   \n",
       "Medical condition in easily understood language      77422  31165   \n",
       "\n",
       "                                                                                                  top  \\\n",
       "EudraCT Number:                                                                        2017-004295-55   \n",
       "Country                                                                                 United States   \n",
       "Member State Concerned                                                                  Spain - AEMPS   \n",
       "Date on which this record was first entered in ...                                         2021-06-17   \n",
       "Date of the global end of the trial                                                        2012-12-20   \n",
       "Trial Status:                                                                               Completed   \n",
       "Therapeutic area                                                          Diseases [C] - Cancer [C04]   \n",
       "Diagnosis                                                                                          No   \n",
       "Prophylaxis                                                                                        No   \n",
       "Therapy                                                                                           Yes   \n",
       "Safety                                                                                            Yes   \n",
       "Efficacy                                                                                          Yes   \n",
       "Main objective of the trial                         Demonstrate that ofatumumab 20 mg sc once ever...   \n",
       "Human pharmacology (Phase I)                                                                       No   \n",
       "Therapeutic exploratory (Phase II)                                                                 No   \n",
       "Therapeutic confirmatory (Phase III)                                                              Yes   \n",
       "Therapeutic use (Phase IV)                                                                         No   \n",
       "In Utero                                                                                           No   \n",
       "Newborns (0-27 days)                                                                               No   \n",
       "Infants and toddlers (28 days-23 months)                                                           No   \n",
       "Children (2-11years)                                                                               No   \n",
       "Adolescents (12-17 years)                                                                          No   \n",
       "Adults (18-64 years)                                                                              Yes   \n",
       "Elderly (>=65 years)                                                                              Yes   \n",
       "Female                                                                                            Yes   \n",
       "Male                                                                                              Yes   \n",
       "Medical condition(s) being investigated                                          Rheumatoid Arthritis   \n",
       "Medical condition in easily understood language                                                Asthma   \n",
       "\n",
       "                                                      freq  \n",
       "EudraCT Number:                                         24  \n",
       "Country                                              17694  \n",
       "Member State Concerned                               11095  \n",
       "Date on which this record was first entered in ...     327  \n",
       "Date of the global end of the trial                     60  \n",
       "Trial Status:                                        66850  \n",
       "Therapeutic area                                     21952  \n",
       "Diagnosis                                           108189  \n",
       "Prophylaxis                                         103340  \n",
       "Therapy                                              63972  \n",
       "Safety                                              103257  \n",
       "Efficacy                                            101944  \n",
       "Main objective of the trial                             27  \n",
       "Human pharmacology (Phase I)                        106469  \n",
       "Therapeutic exploratory (Phase II)                   70268  \n",
       "Therapeutic confirmatory (Phase III)                 60094  \n",
       "Therapeutic use (Phase IV)                           98019  \n",
       "In Utero                                             93835  \n",
       "Newborns (0-27 days)                                 92170  \n",
       "Infants and toddlers (28 days-23 months)             88099  \n",
       "Children (2-11years)                                 82205  \n",
       "Adolescents (12-17 years)                            78255  \n",
       "Adults (18-64 years)                                102709  \n",
       "Elderly (>=65 years)                                 86288  \n",
       "Female                                              109773  \n",
       "Male                                                107306  \n",
       "Medical condition(s) being investigated                694  \n",
       "Medical condition in easily understood language        607  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.describe().transpose()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d8696b7d",
   "metadata": {},
   "source": [
    "We started by defining the agregation funcionts based on the subgroups of columns."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "1bc87dba",
   "metadata": {},
   "outputs": [],
   "source": [
    "def aggregate_columns_phase(row):\n",
    "    yes_columns = [col for col in row.index if col in ['Human pharmacology (Phase I)','Therapeutic exploratory (Phase II)',\n",
    "             'Therapeutic confirmatory (Phase III)','Therapeutic use (Phase IV)'] \n",
    "                   and row[col] == 'Yes']\n",
    "    return ', '.join(yes_columns) if yes_columns else ''"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "44606894",
   "metadata": {},
   "outputs": [],
   "source": [
    "def aggregate_columns_age(row):\n",
    "    yes_columns = [col for col in row.index if col in ['In Utero','Newborns (0-27 days)',\n",
    "             'Infants and toddlers (28 days-23 months)','Children (2-11years)','Adolescents (12-17 years)',\n",
    "             'Adults (18-64 years)','Elderly (>=65 years)'] \n",
    "                   and row[col] == 'Yes']\n",
    "    return ', '.join(yes_columns) if yes_columns else ''"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "21d06035",
   "metadata": {},
   "outputs": [],
   "source": [
    "def aggregate_columns_scope(row):\n",
    "    yes_columns = [col for col in row.index if col in ['Diagnosis', 'Prophylaxis', 'Therapy', 'Safety', 'Efficacy'] \n",
    "                   and row[col] == 'Yes']\n",
    "    return ', '.join(yes_columns) if yes_columns else ''"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "865be247",
   "metadata": {},
   "outputs": [],
   "source": [
    "def aggregate_columns_gender(row):\n",
    "    yes_columns = [col for col in row.index if col in ['Female','Male'] \n",
    "                   and row[col] == 'Yes']\n",
    "    return ', '.join(yes_columns) if yes_columns else ''"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7d7dd886",
   "metadata": {},
   "source": [
    "And then apply the aggregation function to the dataset to group the column values:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "24e0de72",
   "metadata": {},
   "outputs": [],
   "source": [
    "df['Scope of the Trial'] = df.apply(aggregate_columns_scope, axis=1)\n",
    "df['Trial Phase'] = df.apply(aggregate_columns_phase, axis=1)\n",
    "df['Age Group'] = df.apply(aggregate_columns_age, axis=1)\n",
    "df['Gender'] = df.apply(aggregate_columns_gender, axis=1)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6104ae88",
   "metadata": {},
   "source": [
    "Finally, we deleted the unecessary columns. Our new dataset has now 114333rows and 12 columns."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "708aad7f",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.drop(['Diagnosis', 'Prophylaxis', 'Therapy', 'Safety', 'Efficacy',\n",
    "        'Human pharmacology (Phase I)','Therapeutic exploratory (Phase II)',\n",
    "         'Therapeutic confirmatory (Phase III)','Therapeutic use (Phase IV)',\n",
    "         'In Utero','Newborns (0-27 days)', 'Infants and toddlers (28 days-23 months)','Children (2-11years)',\n",
    "         'Adolescents (12-17 years)','Adults (18-64 years)','Elderly (>=65 years)','Female','Male'],\n",
    "        axis=1, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "16832d01",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(114333, 14)"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.shape"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7c94bb67",
   "metadata": {},
   "source": [
    "#### Column Rename and Data Split"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "33d93265",
   "metadata": {},
   "source": [
    "Having reduced the number of columns it was necessary to rename some of the columns to a more intuitive name.\n",
    "\n",
    "Additionally, as we are focusing on depression and neurological diseases we must filter and split the dataset."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "ae4a9928",
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.rename(columns={'Date on which this record was first entered in the EudraCT database:':'Start Date',\n",
    "                         'Member State Concerned':'Member State',\n",
    "                         'Date of the global end of the trial':'End Date',\n",
    "                       'Scope of the Trial':'Trial Scope'})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "29a967ff",
   "metadata": {},
   "outputs": [],
   "source": [
    "depression_trials = df[(df['Therapeutic area'] == 'Psychiatry and Psychology [F] - Mental Disorders [F03]') |\n",
    "                    (df['Therapeutic area'] == 'Psychiatry and Psychology [F] - Behaviours [F01]') |\n",
    "                    (df['Therapeutic area'] == 'Psychiatry and Psychology [F] - Behavioral Disciplines and Activities [F04]') |\n",
    "                    (df['Therapeutic area'] == 'Psychiatry and Psychology [F] - Psychological processes [F02]')] "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "4c032dd1",
   "metadata": {},
   "outputs": [],
   "source": [
    "#neural_trials = df[(df['Therapeutic area'] == 'Diseases [C] - Nervous System Diseases [C10]')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "a343a9d2",
   "metadata": {},
   "outputs": [],
   "source": [
    "neurology_trials = df[(df['Therapeutic area'] == 'Diseases [C] - Nervous System Diseases [C10]') |\n",
    "                    (df['Therapeutic area'] == 'Diseases [C] - Cardiovascular Diseases [C14]')] "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1f5d6b50",
   "metadata": {},
   "source": [
    "### Conclusions and Export"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1ef5f555",
   "metadata": {},
   "source": [
    "The following tables summarize the main information regarding both datasets:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "3c218313",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 1785 entries, 17 to 114272\n",
      "Data columns (total 14 columns):\n",
      " #   Column                                           Non-Null Count  Dtype \n",
      "---  ------                                           --------------  ----- \n",
      " 0   EudraCT Number:                                  1785 non-null   object\n",
      " 1   Country                                          1768 non-null   object\n",
      " 2   Member State                                     1757 non-null   object\n",
      " 3   Start Date                                       1785 non-null   object\n",
      " 4   End Date                                         1042 non-null   object\n",
      " 5   Trial Status:                                    1707 non-null   object\n",
      " 6   Therapeutic area                                 1785 non-null   object\n",
      " 7   Main objective of the trial                      1783 non-null   object\n",
      " 8   Medical condition(s) being investigated          1780 non-null   object\n",
      " 9   Medical condition in easily understood language  1772 non-null   object\n",
      " 10  Trial Scope                                      1785 non-null   object\n",
      " 11  Trial Phase                                      1785 non-null   object\n",
      " 12  Age Group                                        1785 non-null   object\n",
      " 13  Gender                                           1785 non-null   object\n",
      "dtypes: object(14)\n",
      "memory usage: 209.2+ KB\n"
     ]
    }
   ],
   "source": [
    "depression_trials.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "d50a7b78",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>count</th>\n",
       "      <th>unique</th>\n",
       "      <th>top</th>\n",
       "      <th>freq</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>EudraCT Number:</th>\n",
       "      <td>1785</td>\n",
       "      <td>852</td>\n",
       "      <td>2019-002992-33</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Country</th>\n",
       "      <td>1768</td>\n",
       "      <td>31</td>\n",
       "      <td>United States</td>\n",
       "      <td>375</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Member State</th>\n",
       "      <td>1757</td>\n",
       "      <td>28</td>\n",
       "      <td>Germany - BfArM</td>\n",
       "      <td>182</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Start Date</th>\n",
       "      <td>1785</td>\n",
       "      <td>1255</td>\n",
       "      <td>2012-10-22</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>End Date</th>\n",
       "      <td>1042</td>\n",
       "      <td>493</td>\n",
       "      <td>2013-09-03</td>\n",
       "      <td>13</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Trial Status:</th>\n",
       "      <td>1707</td>\n",
       "      <td>8</td>\n",
       "      <td>Completed</td>\n",
       "      <td>1010</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Therapeutic area</th>\n",
       "      <td>1785</td>\n",
       "      <td>4</td>\n",
       "      <td>Psychiatry and Psychology [F] - Mental Disorde...</td>\n",
       "      <td>1493</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Main objective of the trial</th>\n",
       "      <td>1783</td>\n",
       "      <td>1059</td>\n",
       "      <td>Evaluation of the long-term safety and tolerab...</td>\n",
       "      <td>15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Medical condition(s) being investigated</th>\n",
       "      <td>1780</td>\n",
       "      <td>750</td>\n",
       "      <td>Major Depressive Disorder</td>\n",
       "      <td>181</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Medical condition in easily understood language</th>\n",
       "      <td>1772</td>\n",
       "      <td>701</td>\n",
       "      <td>Schizophrenia</td>\n",
       "      <td>160</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Trial Scope</th>\n",
       "      <td>1785</td>\n",
       "      <td>23</td>\n",
       "      <td>Safety, Efficacy</td>\n",
       "      <td>691</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Trial Phase</th>\n",
       "      <td>1785</td>\n",
       "      <td>10</td>\n",
       "      <td>Therapeutic confirmatory (Phase III)</td>\n",
       "      <td>969</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Age Group</th>\n",
       "      <td>1785</td>\n",
       "      <td>13</td>\n",
       "      <td>Adults (18-64 years), Elderly (&gt;=65 years)</td>\n",
       "      <td>709</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Gender</th>\n",
       "      <td>1785</td>\n",
       "      <td>3</td>\n",
       "      <td>Female, Male</td>\n",
       "      <td>1725</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                count unique  \\\n",
       "EudraCT Number:                                  1785    852   \n",
       "Country                                          1768     31   \n",
       "Member State                                     1757     28   \n",
       "Start Date                                       1785   1255   \n",
       "End Date                                         1042    493   \n",
       "Trial Status:                                    1707      8   \n",
       "Therapeutic area                                 1785      4   \n",
       "Main objective of the trial                      1783   1059   \n",
       "Medical condition(s) being investigated          1780    750   \n",
       "Medical condition in easily understood language  1772    701   \n",
       "Trial Scope                                      1785     23   \n",
       "Trial Phase                                      1785     10   \n",
       "Age Group                                        1785     13   \n",
       "Gender                                           1785      3   \n",
       "\n",
       "                                                                                               top  \\\n",
       "EudraCT Number:                                                                     2019-002992-33   \n",
       "Country                                                                              United States   \n",
       "Member State                                                                       Germany - BfArM   \n",
       "Start Date                                                                              2012-10-22   \n",
       "End Date                                                                                2013-09-03   \n",
       "Trial Status:                                                                            Completed   \n",
       "Therapeutic area                                 Psychiatry and Psychology [F] - Mental Disorde...   \n",
       "Main objective of the trial                      Evaluation of the long-term safety and tolerab...   \n",
       "Medical condition(s) being investigated                                  Major Depressive Disorder   \n",
       "Medical condition in easily understood language                                      Schizophrenia   \n",
       "Trial Scope                                                                       Safety, Efficacy   \n",
       "Trial Phase                                                   Therapeutic confirmatory (Phase III)   \n",
       "Age Group                                               Adults (18-64 years), Elderly (>=65 years)   \n",
       "Gender                                                                                Female, Male   \n",
       "\n",
       "                                                 freq  \n",
       "EudraCT Number:                                    14  \n",
       "Country                                           375  \n",
       "Member State                                      182  \n",
       "Start Date                                          6  \n",
       "End Date                                           13  \n",
       "Trial Status:                                    1010  \n",
       "Therapeutic area                                 1493  \n",
       "Main objective of the trial                        15  \n",
       "Medical condition(s) being investigated           181  \n",
       "Medical condition in easily understood language   160  \n",
       "Trial Scope                                       691  \n",
       "Trial Phase                                       969  \n",
       "Age Group                                         709  \n",
       "Gender                                           1725  "
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "depression_trials.describe().transpose()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "00dfa25b",
   "metadata": {},
   "outputs": [],
   "source": [
    "#neural_trials.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "cf69a333",
   "metadata": {},
   "outputs": [],
   "source": [
    "#neural_trials.describe().transpose()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "93b3f187",
   "metadata": {},
   "outputs": [],
   "source": [
    "#depression_trials.to_csv(\"depression_trials.csv\")\n",
    "#neural_trials.to_csv(\"neural_trials.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "d733f63a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 11615 entries, 0 to 114313\n",
      "Data columns (total 14 columns):\n",
      " #   Column                                           Non-Null Count  Dtype \n",
      "---  ------                                           --------------  ----- \n",
      " 0   EudraCT Number:                                  11615 non-null  object\n",
      " 1   Country                                          11452 non-null  object\n",
      " 2   Member State                                     11431 non-null  object\n",
      " 3   Start Date                                       11615 non-null  object\n",
      " 4   End Date                                         6243 non-null   object\n",
      " 5   Trial Status:                                    11251 non-null  object\n",
      " 6   Therapeutic area                                 11615 non-null  object\n",
      " 7   Main objective of the trial                      11615 non-null  object\n",
      " 8   Medical condition(s) being investigated          11551 non-null  object\n",
      " 9   Medical condition in easily understood language  11489 non-null  object\n",
      " 10  Trial Scope                                      11615 non-null  object\n",
      " 11  Trial Phase                                      11615 non-null  object\n",
      " 12  Age Group                                        11615 non-null  object\n",
      " 13  Gender                                           11615 non-null  object\n",
      "dtypes: object(14)\n",
      "memory usage: 1.3+ MB\n"
     ]
    }
   ],
   "source": [
    "neurology_trials.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "8ef61604",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>count</th>\n",
       "      <th>unique</th>\n",
       "      <th>top</th>\n",
       "      <th>freq</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>EudraCT Number:</th>\n",
       "      <td>11615</td>\n",
       "      <td>3732</td>\n",
       "      <td>2012-005012-26</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Country</th>\n",
       "      <td>11452</td>\n",
       "      <td>49</td>\n",
       "      <td>Germany</td>\n",
       "      <td>2199</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Member State</th>\n",
       "      <td>11431</td>\n",
       "      <td>29</td>\n",
       "      <td>Spain - AEMPS</td>\n",
       "      <td>1040</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Start Date</th>\n",
       "      <td>11615</td>\n",
       "      <td>3389</td>\n",
       "      <td>2021-06-17</td>\n",
       "      <td>40</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>End Date</th>\n",
       "      <td>6243</td>\n",
       "      <td>1624</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Trial Status:</th>\n",
       "      <td>11251</td>\n",
       "      <td>10</td>\n",
       "      <td>Completed</td>\n",
       "      <td>6141</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Therapeutic area</th>\n",
       "      <td>11615</td>\n",
       "      <td>2</td>\n",
       "      <td>Diseases [C] - Nervous System Diseases [C10]</td>\n",
       "      <td>6612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Main objective of the trial</th>\n",
       "      <td>11615</td>\n",
       "      <td>5933</td>\n",
       "      <td>Demonstrate that ofatumumab 20 mg sc once ever...</td>\n",
       "      <td>27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Medical condition(s) being investigated</th>\n",
       "      <td>11551</td>\n",
       "      <td>4455</td>\n",
       "      <td>Relapsing Multiple Sclerosis</td>\n",
       "      <td>122</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Medical condition in easily understood language</th>\n",
       "      <td>11489</td>\n",
       "      <td>4310</td>\n",
       "      <td>Epilepsy</td>\n",
       "      <td>315</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Trial Scope</th>\n",
       "      <td>11615</td>\n",
       "      <td>28</td>\n",
       "      <td>Therapy, Safety, Efficacy</td>\n",
       "      <td>4886</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Trial Phase</th>\n",
       "      <td>11615</td>\n",
       "      <td>13</td>\n",
       "      <td>Therapeutic confirmatory (Phase III)</td>\n",
       "      <td>6477</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Age Group</th>\n",
       "      <td>11615</td>\n",
       "      <td>29</td>\n",
       "      <td>Adults (18-64 years), Elderly (&gt;=65 years)</td>\n",
       "      <td>7887</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Gender</th>\n",
       "      <td>11615</td>\n",
       "      <td>4</td>\n",
       "      <td>Female, Male</td>\n",
       "      <td>11484</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                 count unique  \\\n",
       "EudraCT Number:                                  11615   3732   \n",
       "Country                                          11452     49   \n",
       "Member State                                     11431     29   \n",
       "Start Date                                       11615   3389   \n",
       "End Date                                          6243   1624   \n",
       "Trial Status:                                    11251     10   \n",
       "Therapeutic area                                 11615      2   \n",
       "Main objective of the trial                      11615   5933   \n",
       "Medical condition(s) being investigated          11551   4455   \n",
       "Medical condition in easily understood language  11489   4310   \n",
       "Trial Scope                                      11615     28   \n",
       "Trial Phase                                      11615     13   \n",
       "Age Group                                        11615     29   \n",
       "Gender                                           11615      4   \n",
       "\n",
       "                                                                                               top  \\\n",
       "EudraCT Number:                                                                     2012-005012-26   \n",
       "Country                                                                                    Germany   \n",
       "Member State                                                                         Spain - AEMPS   \n",
       "Start Date                                                                              2021-06-17   \n",
       "End Date                                                                                2022-12-31   \n",
       "Trial Status:                                                                            Completed   \n",
       "Therapeutic area                                      Diseases [C] - Nervous System Diseases [C10]   \n",
       "Main objective of the trial                      Demonstrate that ofatumumab 20 mg sc once ever...   \n",
       "Medical condition(s) being investigated                               Relapsing Multiple Sclerosis   \n",
       "Medical condition in easily understood language                                           Epilepsy   \n",
       "Trial Scope                                                              Therapy, Safety, Efficacy   \n",
       "Trial Phase                                                   Therapeutic confirmatory (Phase III)   \n",
       "Age Group                                               Adults (18-64 years), Elderly (>=65 years)   \n",
       "Gender                                                                                Female, Male   \n",
       "\n",
       "                                                  freq  \n",
       "EudraCT Number:                                     22  \n",
       "Country                                           2199  \n",
       "Member State                                      1040  \n",
       "Start Date                                          40  \n",
       "End Date                                            31  \n",
       "Trial Status:                                     6141  \n",
       "Therapeutic area                                  6612  \n",
       "Main objective of the trial                         27  \n",
       "Medical condition(s) being investigated            122  \n",
       "Medical condition in easily understood language    315  \n",
       "Trial Scope                                       4886  \n",
       "Trial Phase                                       6477  \n",
       "Age Group                                         7887  \n",
       "Gender                                           11484  "
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "neurology_trials.describe().T"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "90feff21",
   "metadata": {},
   "outputs": [],
   "source": [
    "depression_trials.to_csv(\"depression_trials.csv\")\n",
    "neurology_trials.to_csv(\"neurology_trials.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "19a79df7",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
